United Therapeutics Corp.
(NASDAQ : UTHR)

( )
UTHR After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
VRXValeant Pharmaceuticals International, Inc. 1.44%30.2414.1%$177.94m
HZNPHorizon Therapeutics Plc -0.19%91.455.5%$174.64m
GWPHGW Pharmaceuticals Plc 0.17%218.366.1%$132.57m
CTLTCatalent, Inc. 0.86%109.982.1%$128.58m
BHCBausch Health Cos., Inc. 1.44%30.240.0%$123.31m
ICLRICON plc -0.81%196.434.2%$121.81m
UTHRUnited Therapeutics Corp. 1.75%202.7814.1%$98.97m
JAZZJazz Pharmaceuticals Plc 1.87%166.372.3%$88.00m
SAVACassava Sciences, Inc. -1.00%35.670.0%$69.79m
ARGXargenx SE 1.41%272.780.0%$50.95m
SAGESAGE Therapeutics, Inc. 5.19%75.677.6%$37.98m
PRGOPerrigo Co. Plc 0.65%40.416.9%$37.14m
AMRNAmarin Corp. Plc 0.59%5.111.5%$28.81m
PCRXPacira Biosciences, Inc. 1.71%69.439.9%$26.96m
ICPTIntercept Pharmaceuticals, Inc. 1.13%21.4116.8%$21.61m

Company Profile

United Therapeutics Corp. operates as a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening diseases. The firm markets and sells commercial therapies to treat pulmonary arterial hypertension and high-risk neuroblastoma. It also involves in the research and development of new indications and delivery devices for its product and for the organ transplantation-related technologies. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.